-
141
Urinary prostaglandin metabolites evaluation for activity monitoring in inflammatory bowel disease
Published 2025-01-01Subjects: Get full text
Article -
142
Host-microbe multi-omics and succinotype profiling have prognostic value for future relapse in patients with inflammatory bowel disease
Published 2025-12-01Subjects: Get full text
Article -
143
Prospects of Using Microbiota Correction Methods in the Treatment of Inflammatory Bowel Disease
Published 2019-05-01Subjects: Get full text
Article -
144
Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice
Published 2025-01-01Subjects: Get full text
Article -
145
Engineering probiotic Escherichia coli for inflammation-responsive indoleacetic acid production using RiboJ-enhanced genetic circuits
Published 2025-01-01Subjects: Get full text
Article -
146
Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease
Published 1998-01-01Subjects: Get full text
Article -
147
Chick Early Amniotic Fluid Alleviates Dextran-Sulfate-Sodium-Induced Colitis in Mice via T-Cell Receptor Pathway
Published 2025-01-01Subjects: Get full text
Article -
148
-
149
Evaluation of dietary quality in patients with functional gastrointestinal symptoms: a Norwegian single centre study
Published 2024-12-01Subjects: Get full text
Article -
150
Harnessing 3D models to uncover the mechanisms driving infectious and inflammatory disease in the intestine
Published 2024-12-01Subjects: Get full text
Article -
151
Methyl 3-Bromo-4,5-dihydroxybenzoate Attenuates Inflammatory Bowel Disease by Regulating TLR/NF-κB Pathways
Published 2025-01-01Subjects: Get full text
Article -
152
Management of anaemia in patients with inflammatory bowel disease – results of a questionnaire among Polish healthcare professionals
Published 2021-03-01Subjects: Get full text
Article -
153
Polyphenol from foxtail millet bran alleviates experimental colitis in mice by remodulating intestinal fungal community
Published 2024-11-01Subjects: Get full text
Article -
154
Cardiovascular safety of Janus kinase inhibitors in inflammatory bowel disease: a systematic review and network meta-analysis
Published 2025-12-01Subjects: “…Inflammatory bowel disease…”
Get full text
Article -
155
Amelioration of dextran sodium sulphate-induced colitis in mice by treatment with Lactobacillus rhamnosus and Lactobacillus reuteri: intraspecific and interspecific patterns
Published 2024-09-01Subjects: “…inflammatory bowel disease…”
Get full text
Article -
156
Brain-derived neurotrophic factor – a key player in the gastrointestinal system
Published 2023-11-01Subjects: Get full text
Article -
157
Structural equation modeling of the impact of disease activity on inflammatory bowel disease control: the mediating roles of self-efficacy and self-management behaviors
Published 2025-01-01Subjects: “…Inflammatory Bowel Disease (IBD)…”
Get full text
Article -
158
Comparative analysis of dominant gut microbiota in Inflammatory Bowel Disease patients and healthy individuals: A case-control study
Published 2025-04-01Subjects: “…Inflammatory Bowel Disease (IBD)…”
Get full text
Article -
159
WKB ameliorates DSS-induced colitis through inhibiting enteric glial cells activation and altering the intestinal microbiota
Published 2025-01-01Subjects: “…Inflammatory bowel disease…”
Get full text
Article -
160
Clinical entity-aware domain adaptation in low resource setting for inflammatory bowel disease
Published 2025-01-01Subjects: Get full text
Article